Persistent HIV transcription and variable antiretroviral drug penetration in lymph nodes during plasma viral suppression-Reference-Cited by-同舟云学术

Persistent HIV transcription and variable antiretroviral drug penetration in lymph nodes during plasma viral suppression

Published:2022-02-18 Issue:7 Volume:36 Page:985-990
ISSN:0269-9370
Container-title:AIDS
language:en
Short-container-title:

Author:

Fletcher Courtney V.,Kroon Eugène,Schacker Timothy,Pinyakorn Suteeraporn,Chomont Nicolas,Chottanapund Suthat,Prueksakaew Peeriya,Benjapornpong Khunthalee,Buranapraditkun Supranee,Phanuphak Nittaya,Ananworanich Jintanat,Vasan Sandhya,Hsu Denise

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Infectious Diseases,Immunology,Immunology and Allergy

Reference30 articles.

1. Defining total-body AIDS-virus burden with implications for curative strategies;Estes;Nat Med,2017

2. Persistent HIV-1 replication is associated with lower antiretroviral drug concentrations in lymphatic tissues;Fletcher;Proc Natl Acad Sci USA,2014

3. HIV persists throughout deep tissues with repopulation from multiple anatomical sources;Chaillon;J Clin Invest,2020

4. Persistent HIV-1 replication maintains the tissue reservoir during therapy;Lorenzo-Redondo;Nature,2016

5. Quantitative imaging analysis of the spatial relationship between antiretrovirals, reverse transcriptase Simian-human immunodeficiency virus RNA, and collagen in the mesenteric lymph nodes of nonhuman primates;Scholz;Anti- microb Agents Chemother,2021

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Plasma, intracellular and lymph node antiretroviral concentrations and HIV DNA change during primary HIV infection: Results from the INACTION P25 study;International Journal of Antimicrobial Agents;2024-08

2. Long-term effects on immunological, inflammatory markers, and HIV-1 reservoir after switching to a two-drug versus maintaining a three-drug regimen based on integrase inhibitors;Frontiers in Immunology;2024-07-11

3. High concentrations of Maraviroc do not alter immunological and metabolic parameters of CD4 T cells;Scientific Reports;2024-06-17

4. Distribution of lamivudine into lymph node HIV reservoir;International Journal of Pharmaceutics;2023-12

5. HIV-1-specific T-cell responses and exhaustion profiles in people with HIV after switching to dual therapy vs. maintaining triple therapy based on integrase inhibitors;Biomedicine & Pharmacotherapy;2023-12